Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • The Effect of Tranexamic Acid on Calculated Total Blood Loss in Patients undergoing Revision Shoulder Arthroplasty

    The purpose of this research study is to evaluate how well Tranexamic Acid (TXA) reduces total blood loss, surgical drain output (fluids released at the ...

    View Details

  • Severe Acute Respiratory Infection - Preparedness

    This is a study screening for patients with suspected viral SARI. The purpose of the study is to collect samples and information about infections due ...

    View Details

  • Comparison of office-based KTP and CO2 laser outcomes in patients with vocal cord lesions.

    The purpose of this study is to test the outcomes of a CO2 laser device called AcuPulse Duo on vocal lesions and compare them to ...

    View Details

  • Phase 3 Randomized Double-Blind Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2

    The study is researching an experimental drug combination REGN10933 and REGN10987, given as separate subcutaneous (SC, under the skin) injections. REGN10933 and REGN10987 will sometimes ...

    View Details

  • A Phase I/II Study of Nivolumab plus or minus Ipilimumab in Combination with Multi-fraction Stereotactic Radiosurgery for Recurrent High-grade Radiation-relapsed Meningioma

    The purpose of the study is to examine the safety when combining nivolumab with or without ipilimumab (two different types of immunotherapy drugs) with radiosurgery ...

    View Details

  • A Phase I study of Anetumab Ravtansine in Combination with either Anti-PD-1 Antibody or Anti-CTLA4 and Anti-PD-1 Antibodies or Anti-PD-1 Antibody and Gemcitabine in Mesothelin-Positive Advanced Pancreatic Adenocarcinoma

    The purpose of the study is to determine the side effects and best dose of anetumab ravtansine when given together with nivolumab, ipilimumab and gemcitabine ...

    View Details

  • A randomized Phase I/II trial of fulvestrant and abemaciclib in combination with copanlisib (FAC) versus fulvestrant and abemaciclib alone (FA) for endocrine-resistant hormone receptor positive HER2 negative metastatic breast cancer (FAC vs FA)

    The purpose of the study is to determine the effects (good and bad) of adding copanlisib to the usual therapy of fulvestrant and abemaciclib in ...

    View Details

  • Phase I/II study of dabrafenib trametinib and navitoclax in BRAF mutant melanoma (Phase I and II) and other solid tumors (Phase I only).

    The purpose of the study is to determine the side effects and best dose of dabrafenib, trametinib, and navitoclax and to see how well they ...

    View Details